Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome

Clinical Journal of Pain

Volumn 22, Issue 3, 2006, Pages 235-239

  Schinkel, Christian ^a,d   Gaertner, Andreas ^b   Zaspel, Johannes ^b   Zedler, Siegfried ^b   Faist, Eugen ^b   Schuermann, Matthias ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Klinikum Hof   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Complex regional pain syndrome; Inflammation; Reflex dystrophy; Substance P

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCITONIN GENE RELATED PEPTIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; NEUROPEPTIDE Y; PADGEM PROTEIN; SUBSTANCE P; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; AUTACOID; CYTOKINE; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MALE; POSTTRAUMATIC PAIN; PRIORITY JOURNAL; BLOOD; CLINICAL TRIAL; INJURY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; REFLEX SYMPATHETIC DYSTROPHY; SUBSTANCE P; WOUNDS AND INJURIES;

EID: 33645739008     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ajp.0000169669.70523.f0     Document Type: Article

References (48)

1. Stanton-Hicks M, Janig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;63:127-133.
2. Atkins RM, Duckworth T, Kanis JA. Features of algodystrophy after Colles fracture. J Bone Joint Surg [Br]. 1990;72:105-110.
3. Field J, Atkins RM. Algodystrophy is an early complication of Colles fracture. What are the implications? J Hand Surg [Br]. 1997;22:178-182.
4. Rowbotham MC, Twilling L, Davies PS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Complex regional pain syndrome-diagnostic, mechanisms, CNS involvement and therapy. N Engl J Med. 2003;348:1223-1232.
5. Wasner G, Schattschneider J, Binder A, et al. Recent trends in understanding and therapy of complex regional pain syndromes. Anaesthesist. 2003;52:883-895.
6. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524-1534.
7. Chelimsky TC, Low PA, Naessens JM, et al. Value of autonomic testing in reflex sympathetic dystrophy. Mayo Clin Proc. 1995;70:1029-1040.
8. AbuRahma AF, Robinson PA, Powell M, et al. Sympathectomy for reflex sympathetic dystrophy: factors affecting outcome. Ann Vasc Surg. 1994;8:372-379.
9. Olcott CT, Eltherington LG, Wilcosky BR, et al. Reflex sympathetic dystrophy: the surgeon's role in management. J Vasc Surg. 1991;14:488-495.
10. Arnold JM, Teasell RW, MacLeod AP, et al. Increased venous alpha-adrenoceptor responsiveness in patients with reflex sympathetic dystrophy. Ann Intern Med. 1993;118:619-621.
11. Goris RJ, Dongen LM, Winters HA. Are toxic oxygen radicals involved in the pathogenesis of reflex sympathetic dystrophy? Free Radic Res Commun. 1987;3:13-18.
12. Oyen WJ, Arntz IE, Claessens RM, et al. Reflex sympathetic dystrophy of the hand: an excessive inflammatory response? Pain. 1993;55:151-157.
13. Schott GD. Visceral afferents: their contribution to "sympathetic dependent" pain. Brain. 1994;117:397-413.
14. Schurmann M, Zaspel J, Gradl G, et al. Assessment of the peripheral microcirculation using computer-assisted venous congestion plethysmography in post-traumatic complex regional pain syndrome type I. J Vasc Res. 2001;38:453-461.
15. Bruehl S, Harden RN, Galer BS, et al. External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. Pain. 1999;81:147-154.
16. Bonica J. Causalgia and other reflex sympathetic dystrophies. In: Bonica J, Liebeskind J, Albe-Fessard D, eds. Advances in Pain Research. New York: Raven Press; 1979:141-166.
17. Baron R, Binder A, Ulrich W, et al. Complex regional pain syndrome. Reflex sympathetic dystrophy and causalgia. Nervenarzt. 2002;73:305-319.
18. Drummond PD, Finch PM, Edvinsson L, et al. Plasma neuropeptide Y in the symptomatic limb of patients with causalgic pain. Clin Auton Res. 1994;4:113-116.
19. Harden RN, Duc TA, Williams TR, et al. Norepinephrine and epinephrine levels in affected versus unaffected limbs in sympathetically maintained pain. Clin J Pain. 1994;10:324-330.
20. Blanchard J, Ramamurthy S, Walsh N, et al. Intravenous regional sympatholysis: a double-blind comparison of guanethidine, reserpine, and normal saline. J Pain Symptom Manage. 1990;5:357-361.
21. Sudeck P. The so-called acute bone atrophy as an inflammatory process. Chirurgie. 1942;14:449-458.
22. Christensen K, Jensen EM, Noer I. The reflex dystrophy syndrome response to treatment with systemic corticosteroids. Acta Chir Scand. 1982;148:653-655.
23. Goris RJ. Reflex sympathetic dystrophy: model of a severe regional inflammatory response syndrome. World J Surg. 1998;22:197-202.
24. Baggiolini M, Moser B, Clark-Lewis I. Interleukin-8 and related chemotactic cytokines. Chest. 1994;105:95S-98S.
25. Lin RY, Astiz ME, Saxon JC, et al. Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med. 1994;22:1595-1602.
26. Van Zee KJ, DeForge LE, Fischer E, et al. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol. 1991;146:3478-3482.
27. Cinat M, Waxman K, Vaziri ND, et al. Soluble cytokine receptors and receptor antagonists are sequentially released after trauma. J Trauma. 1995;39:112-120.
28. Hensler T, Sauerland S, Bouillon B, et al. Association between injury pattern of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10, and polymorphonuclear neutrophil elastase. J Trauma. 2002;52:962-970.
29. Yamada Y, Endo S, Inada K, et al. Tumor necrosis factor-alpha and tumor necrosis factor receptor I, II levels in patients with severe burns. Burns. 2000;26:239-244.
30. van de Beek WJ, Remarque EJ, Westendorp RG, et al. Innate cytokine profile in patients with complex regional pain syndrome is normal. Pain. 2001;91:259-261.
31. Rommel O, Malin JP, Zenz M, et al. Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits. Pain. 2001;93:279-293.
32. Huygen FJ, De Bruijn AG, De Bruijn MT, et al. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 2002;11:47-51.
33. Schinkel C, Faist E, Zimmer S, et al. Kinetics of circulating adhesion molecules and chemokines after mechanical trauma and burns. Eur J Surg. 1996;162:763-768.
34. Newman W, Beall LD, Carson CW, et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol. 1993;150:644-654.
35. Gamble JR, Skinner MP, Berndt MC, et al. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science. 1990;249:414-417.
36. Blair S. Role of the neuropeptides in the pathogenesis of reflex sympathetic dystrophy. Programs and Abstracts of Reflex Sympathetic Dystrophy, Brussels, 1996.
37. Joos GF, Germonpre PR, Pauwels RA. Role of tachykinins in asthma. Allergy. 2000;55:321-337.
38. Lecci A, Giuliani S, Tramontana M, et al. Peripheral actions of tachykinins. Neuropeptides. 2000;34:303-313.
39. Linnik MD, Moskowitz MA. Identification of immunoreactive substance P in human and other mammalian endothelial cells. Peptides. 1989;10:957-962.
40. Ho WZ, Lai JP, Zhu XH, et al. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol. 1997;159:5654-5660.
41. Lai JP, Douglas SD, Zhao M, et al. Quantification of substance P mRNA in human mononuclear phagocytes and lymphocytes using a mimic-based RT-PCR. J Immunol Methods. 1999;230:149-157.
42. De Giorgio R, Tazzari PL, Barbara G, et al. Detection of substance P immunoreactivity in human peripheral leukocytes. J Neuroimmunol. 1998;82:175-181.
43. Lambrecht BN, Germonpre PR, Everaert EG, et al. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol. 1999;29:3815-3825.
44. Iwamoto I, Nakagawa N, Yamazaki H, et al. Mechanism for substance P-induced activation of human neutrophils and eosinophils. Regul Pept. 1993;46:228-230.
45. Schratzberger P, Reinisch N, Prodinger WM, et al. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol. 1997;158:3895-3901.
46. Chancellor-Freeland C, Zhu GF, Kage R, et al. Substance P and stress-induced changes in macrophages. Ann NY Acad Sci. 1995;771:472-484.
47. Miller-Graziano C, Laudanski K. Substance P modulates monocyte expression and differentiation. Surg Infection. 2002;3:98.
48. Weber M, Birklein F, Neundorfer B, et al. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain. 2001;91:251-257.